Dapagliflozin Reduces Hospitalizations Among Patients With CKD
Reduction seen in rate of admissions due to cardiac disorders, renal and urinary disorders, metabolism and nutrition disorders, neoplasms
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.